{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:39:53Z","timestamp":1791203993738,"version":"4.2.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bone.2020.115625","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T12:40:40Z","timestamp":1599050440000},"page":"115625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits"],"prefix":"10.1016","volume":"141","author":[{"given":"Kathryn M.","family":"Thrailkill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Clay","family":"Bunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasidhar","family":"Uppuganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Kalaitzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Fowlkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry S.","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bone.2020.115625_bb0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.bone.2020.115625_bb0010","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","article-title":"Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women","volume":"24","author":"Nicodemus","year":"2001","journal-title":"Diabetes Care"},{"issue":"21","key":"10.1016\/j.bone.2020.115625_bb0015","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"Jama."},{"issue":"3","key":"10.1016\/j.bone.2020.115625_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/dc07-1152","article-title":"Diabetes-related complications, glycemic control, and falls in older adults","volume":"31","author":"Schwartz","year":"2008","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.bone.2020.115625_bb0025","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","article-title":"Bone quality assessment in type 2 diabetes mellitus","volume":"25","author":"Dhaliwal","year":"2014","journal-title":"Osteoporosis Int."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2020.115625_bb0030","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1055\/s-2007-972713","article-title":"The Saskatchewan Pediatric Bone Mineral Accrual Study: bone mineral acquisition during the growing years","volume":"18","author":"Bailey","year":"1997","journal-title":"Int. J. Sports Med."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","article-title":"Type 2 diabetes in adolescents and young adults","volume":"6","author":"Lascar","year":"2018","journal-title":"Lancet Diabe. Endocrinol."},{"issue":"9","key":"10.1016\/j.bone.2020.115625_bb0040","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/dc16-1066","article-title":"Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities","volume":"39","author":"Nadeau","year":"2016","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.bone.2020.115625_bb0045","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bone.2020.115625_bb0050","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY","volume":"36","author":"Group TS","year":"2013","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.bone.2020.115625_bb0055","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"Group TS","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bone.2020.115625_bb0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jdiacomp.2016.02.009","article-title":"Diabetes complications in childhood and adolescent onset type 2 diabetes-a review","volume":"30","author":"Amutha","year":"2016","journal-title":"J. Diabetes Complicat."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jdiacomp.2014.10.009","article-title":"Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial","volume":"29","author":"Tryggestad","year":"2015","journal-title":"J. Diabetes Complicat."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/joe.1.06647","article-title":"Phenotypic characterization of polygenic type 2 diabetes in TALLYHO\/JngJ mice","volume":"191","author":"Kim","year":"2006","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2020.115625_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/geno.2001.6569","article-title":"Genetic analysis of a new mouse model for non-insulin-dependent diabetes","volume":"74","author":"Kim","year":"2001","journal-title":"Genomics."},{"key":"10.1016\/j.bone.2020.115625_bb0080","series-title":"Animal Models in Diabetes Research Methods in Molecular Biology (Methods and Protocols)","article-title":"The TallyHO mouse as a model of human type 2 diabetes","author":"Kim","year":"2012"},{"issue":"10","key":"10.1016\/j.bone.2020.115625_bb0085","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1210\/en.2014-1041","article-title":"Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO\/JngJ mouse","volume":"155","author":"Devlin","year":"2014","journal-title":"Endocrinology."},{"key":"10.1016\/j.bone.2020.115625_bb0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bone.2018.02.005","article-title":"Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age","volume":"110","author":"Creecy","year":"2018","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/db14-0393","article-title":"Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice","volume":"64","author":"Neschen","year":"2015","journal-title":"Diabetes."},{"key":"10.1016\/j.bone.2020.115625_bb0100","series-title":"Cardiovascular Protection With SGLT2 Inhibitors in Type 2 Diabetes Mellitus: Does it Apply to all Patients? Diabetes, Obesity & Metabolism","author":"Giorgino","year":"2020"},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2020.115625_bb0110","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00125-019-4955-5","article-title":"Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS program","volume":"62","author":"Zhou","year":"2019","journal-title":"Diabetologia."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13300-019-00724-w","article-title":"Sodium-glucose co-transporter 2 inhibitors and fracture risk","volume":"11","author":"Erythropoulou-Kaltsidou","year":"2020","journal-title":"Diab. Ther."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.bone.2020.115625_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bone.2016.10.026","article-title":"The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes","volume":"94","author":"Thrailkill","year":"2017","journal-title":"Bone."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0140","doi-asserted-by":"crossref","first-page":"E981","DOI":"10.1152\/ajpendo.90283.2008","article-title":"Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c","volume":"295","author":"Han","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115625_bb0145","doi-asserted-by":"crossref","first-page":"115126","DOI":"10.1016\/j.bone.2019.115126","article-title":"The age-related decrease in material properties of BALB\/c mouse long bones involves alterations to the extracellular matrix","volume":"130","author":"Creecy","year":"2020","journal-title":"Bone."},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2010.12.016","article-title":"Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone","volume":"48","author":"Nyman","year":"2011","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115625_bb0155","doi-asserted-by":"crossref","first-page":"703589","DOI":"10.1155\/2014\/703589","article-title":"Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone","volume":"2014","author":"Thrailkill","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bone.2020.115625_bb0160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bone.2015.11.009","article-title":"Age-related changes in the fracture resistance of male Fischer F344 rat bone","volume":"83","author":"Uppuganti","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115625_bb0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1196\/annals.1346.039","article-title":"Bone strength: current concepts","volume":"1068","author":"Turner","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2020.115625_bb0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bone.2017.09.001","article-title":"Evidence of disordered calcium metabolism in adolescent girls with type 1 diabetes: an observational study using a dual-stable calcium isotope technique","volume":"105","author":"Weber","year":"2017","journal-title":"Bone."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1542\/peds.78.2.298","article-title":"Hypercalciuria, hyperphosphaturia, and growth retardation in children with diabetes mellitus","volume":"78","author":"Malone","year":"1986","journal-title":"Pediatrics."},{"issue":"5 Pt 1","key":"10.1016\/j.bone.2020.115625_bb0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(05)81898-0","article-title":"Hypercalciuria in children with renal glycosuria: evidence of dual renal tubular reabsorptive defects","volume":"121","author":"Schneider","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2020.115625_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223350","article-title":"Glucosuria without diabetes: key to the diagnosis of fragility fractures due to Fanconi syndrome","volume":"2018","author":"Alacapa","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(87)90081-7","article-title":"Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia","volume":"82","author":"Rao","year":"1987","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MNH.0000000000000505","article-title":"Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus","volume":"28","author":"Vinke","year":"2019","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0200","first-page":"118","article-title":"Bone disease in primary hypercalciuria","volume":"5","author":"Sella","year":"2008","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"12","key":"10.1016\/j.bone.2020.115625_bb0205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.5650071205","article-title":"Reduced vertebral bone density in hypercalciuric nephrolithiasis","volume":"7","author":"Pietschmann","year":"1992","journal-title":"J. Bone. Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2020.115625_bb0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1490209","article-title":"Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis","volume":"149","author":"Giannini","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2020.115625_bb0215","first-page":"1916","article-title":"A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis","volume":"83","author":"Heshmati","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0220","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1699-0463.1989.tb00793.x","article-title":"A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria","volume":"97","author":"Steiniche","year":"1989","journal-title":"APMIS."},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0225","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jcem-50-4-654","article-title":"Abnormal bone histology in idiopathic hypercalciuria","volume":"50","author":"Malluche","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ki.1996.34","article-title":"Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria","volume":"49","author":"Weisinger","year":"1996","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0235","first-page":"19","article-title":"Bone mineral content in idiopathic calcium nephrolithiasis","volume":"11","author":"Barkin","year":"1985","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.bone.2020.115625_bb0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2015.07.025","article-title":"SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA\/2J male mice","volume":"82","author":"Thrailkill","year":"2016","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1450011","article-title":"The effect of diabetes mellitus on urinary calcium excretion in pregnant rats and their offspring","volume":"145","author":"Birdsey","year":"1995","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2020.115625_bb0250","doi-asserted-by":"crossref","first-page":"115254","DOI":"10.1016\/j.bone.2020.115254","article-title":"Genetic ablation of SGLT2 function in mice impairs tissue mineral density but does not affect fracture resistance of bone","volume":"133","author":"Thrailkill","year":"2020","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115625_bb0255","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3389\/fendo.2019.00700","article-title":"Dapagliflozin attenuates hyperglycemia related osteoporosis in ZDF rats by alleviating hypercalciuria","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.bone.2020.115625_bb0260","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","article-title":"Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats","volume":"17","author":"Saito","year":"2006","journal-title":"Osteoporosis Int."},{"issue":"3","key":"10.1016\/j.bone.2020.115625_bb0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-016-0149-z","article-title":"Changes in the fracture resistance of bone with the progression of type 2 diabetes in the ZDSD rat","volume":"99","author":"Creecy","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115625_bb0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bone.2016.08.003","article-title":"Effects of insulin therapy on porosity, non-enzymatic glycation and mechanical competence in the bone of rats with type 2 diabetes mellitus","volume":"91","author":"Campbell","year":"2016","journal-title":"Bone."},{"issue":"6","key":"10.1016\/j.bone.2020.115625_bb0275","article-title":"The effects of resistance training on bone mineral density and bone quality in type 2 diabetic rats","volume":"7","author":"Ikedo","year":"2019","journal-title":"Phys. Rep."},{"issue":"11","key":"10.1016\/j.bone.2020.115625_bb0280","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus","volume":"95","author":"Burghardt","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0285","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J. Bone .Miner, Res."},{"issue":"2","key":"10.1016\/j.bone.2020.115625_bb0290","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","article-title":"Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J. Bone .Miner, Res."},{"issue":"1","key":"10.1016\/j.bone.2020.115625_bb0295","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jbmr.3240","article-title":"Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study","volume":"33","author":"Samelson","year":"2018","journal-title":"J. Bone .Miner, Res."},{"issue":"9","key":"10.1016\/j.bone.2020.115625_bb0300","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s00198-016-3614-7","article-title":"Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics","volume":"27","author":"Heilmeier","year":"2016","journal-title":"Osteoporosis Int."},{"issue":"12","key":"10.1016\/j.bone.2020.115625_bb0305","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00198-018-4678-3","article-title":"The association between diabetes status, HbA1c, diabetes duration, microvascular disease, and bone quality of the distal radius and tibia as measured with high-resolution peripheral quantitative computed tomography-the Maastricht study","volume":"29","author":"EAC","year":"2018","journal-title":"Osteoporosis Int."},{"issue":"4","key":"10.1016\/j.bone.2020.115625_bb0310","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.3044","article-title":"Lactation-induced changes in the volume of osteocyte lacunar-canalicular space alter mechanical properties in cortical bone tissue","volume":"32","author":"Kaya","year":"2017","journal-title":"J. Bone .Miner, Res."},{"issue":"3","key":"10.1016\/j.bone.2020.115625_bb0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00223-020-00720-4","article-title":"Dapagliflozin and liraglutide therapies rapidly enhanced bone material properties and matrix biomechanics at bone formation site in a type 2 diabetic mouse model","volume":"107","author":"Mieczkowska","year":"2020","journal-title":"Calcif. Tissue Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:54:06Z","timestamp":1757613246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220304051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":63,"alternative-id":["S8756328220304051"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115625","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115625"}}